ionis
The Director, US Value & Access leads the development and execution of comprehensive market access and value strategies for Ionis's therapeutic portfolio, ensuring optimal patient access and commercial success across the product lifecycle. This senior role collaborates cross‑functionally with Commercial, Medical, HEOR, and Regulatory teams, shaping payer strategy, evidence generation, and value communication while leading and developing a high‑performing market access team.
Ionis Pharmaceuticals is a biotechnology company pioneering RNA- and DNA-targeted medicines—notably antisense oligonucleotide technology—to create therapies for serious diseases. The company focuses on areas such as neurology, cardiology, and rare diseases, advancing a broad pipeline designed to modulate gene expression and change disease course. Ionis develops programs internally and through strategic partnerships with global biopharma companies to translate discoveries into approved medicines. Its mission is to transform healthcare and improve patient lives through groundbreaking scientific innovation.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ionis.
7% above the average for this role
Sr Director, US Medical Early Assets - Market Access
AstraZeneca
US Medical Early Asset Director – Market Access
AstraZeneca
Vice President, Access, Value Evidence & Pricing
Rocket Pharmaceuticals
Director, Payer & Value Marketing
Kite Pharma
Senior Director of U.S. Market Access Strategy
Regeneron Pharmaceuticals
Global Health Economics & Outcomes Research (HEOR) Director
Ipsen